Following a diabetogenic T cell from genesis through pathogenesis

Area of Science:

• Immunology
• Endocrinology
• Genetics

Background:

• Nonobese diabetic (NOD) mice spontaneously develop type 1 diabetes, mirroring the human condition.
• Understanding the genetic and cellular mechanisms driving type 1 diabetes is crucial for developing effective therapies.

Purpose of the Study:

• To generate a transgenic mouse model expressing diabetogenic T cell receptor genes from NOD mice.
• To investigate T cell tolerance and disease development in the context of specific T cell receptor expression.
• To elucidate protective mechanisms against insulitis and diabetes in NOD mice.

Main Methods:

• Generation of transgenic mice carrying rearranged T cell receptor genes from a diabetogenic NOD T cell clone.
• Analysis of T cell tolerance, insulitis, and diabetes development in the transgenic model.
• Comparison of disease progression in transgenic mice with and without the protective E molecule.

Main Results:

• Transgenic mice exhibited self-reactive T cells that were not tolerized, leading to insulitis and diabetes.
• The disease progression in transgenics highlighted key checkpoints relevant to both NOD and human type 1 diabetes.
• Transgenic mice lacking the protective E molecule still developed diabetes, aiding in the exclusion of certain protective mechanisms.

Conclusions:

• Transgenic expression of specific diabetogenic T cell receptors recapitulates key features of type 1 diabetes.
• This model provides a valuable tool for dissecting T cell tolerance and identifying therapeutic targets.
• The study offers insights into the complex interplay of genetics and immune response in type 1 diabetes pathogenesis.